Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alx Oncology Holdings (ALXO) Other Non-Current Liabilities (2019 - 2023)

Alx Oncology Holdings' Other Non-Current Liabilities history spans 5 years, with the latest figure at $6.6 million for Q3 2023.

  • For Q3 2023, Other Non-Current Liabilities rose 21.07% year-over-year to $6.6 million; the TTM value through Sep 2023 reached $6.6 million, up 21.07%, while the annual FY2022 figure was $5.3 million, 188.8% up from the prior year.
  • Other Non-Current Liabilities for Q3 2023 was $6.6 million at Alx Oncology Holdings, up from $6.2 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $6.6 million in Q3 2023 and bottomed at $5000.0 in Q4 2020.
  • The 5-year median for Other Non-Current Liabilities is $2.3 million (2021), against an average of $3.2 million.
  • The largest annual shift saw Other Non-Current Liabilities tumbled 99.09% in 2020 before it skyrocketed 36680.0% in 2021.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $547000.0 in 2019, then crashed by 99.09% to $5000.0 in 2020, then surged by 36680.0% to $1.8 million in 2021, then skyrocketed by 188.8% to $5.3 million in 2022, then rose by 24.99% to $6.6 million in 2023.
  • Per Business Quant, the three most recent readings for ALXO's Other Non-Current Liabilities are $6.6 million (Q3 2023), $6.2 million (Q2 2023), and $6.4 million (Q1 2023).